Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rangering i aksjer #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aksjekurs
$0.16240909
Sist synkronisert: 2025-03-04
Markedsverdi
$35.68M
Endring (1 dag)
0.27%
Endring (1 år)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategori

P/B-forhold for Dali Pharmaceuticalco.,Ltd (603963)
P/B-forhold per August 2026 TTM: 0.69
Ifølge Dali Pharmaceuticalco.,Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0.69. Ved slutten av 2022 hadde selskapet et P/B-forhold på 7.15.
P/B-historikk for Dali Pharmaceuticalco.,Ltd fra 2012 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 0.69 -90.07%
2023 6.94 -3.00%
2022 7.15 54.26%
2021 4.64 27.40%
2020 3.64 -10.88%
2019 4.08 16.91%
2018 3.49 -22.46%
2017 4.51 -29.63%
2016 6.40 36.88%
2015 4.68 39.56%
2014 3.35 -4.78%
2013 3.52 -35.78%
2012 5.48 0.00%
P/B-forhold for lignende selskaper eller konkurrenter